Four years, single surgeon, 114 robotic gynecological surgeries: an institutional audit from India with the Cambridge medical robotics Versius robot

Background: Robotic-assisted surgery is transforming minimally invasive gynecology by offering enhanced precision, superior visualization, and ergonomic advantages over conventional laparoscopy. The Versius surgical system is a newer, modular alternative with lower infrastructure needs. However, published evidence on Versius use in gynecological surgery, particularly from India, is limited. This study evaluates a single-centre, single-surgeon experience with the Versius system over four years. Objectives were to assess the safety, feasibility, and effectiveness of robotic gynecological surgeries performed using the Versius system at a tertiary hospital in Delhi, India, over a 4-year period. Methods: A retrospective review covered 114 consecutive benign gynecological procedures performed using Versius between July 2021 and July 2025 at PSRI hospital, Delhi. Data on patient demographics, surgical types, operative times, blood loss, complications, and hospital stay were analyzed. Results: Robotic hysterectomy was the most common procedure (61.4%), followed by myomectomy (15%) and endometriosis surgery (12%). The mean operative time for hysterectomy was 174 minutes. Blood loss was ≤100 mL in 78% of cases. Intraoperative complications occurred in 7.9%, primarily hemorrhage, with two conversions to open or laparoscopic surgery. Postoperative recovery was uneventful in 97.5%, with a mean hospital stay of 1.08 days; most (91%) were discharged within 24 hours. Conclusions: Versius robotic gynecological surgery is safe, feasible, and effective in an Indian tertiary setting, highlighting its promise as a cost-effective platform with low complications, minimal blood loss, and short hospital stays.